Arbutus Biopharma Corporation (ABUS) Net Income by Year
Arbutus Biopharma Corporation reported a net loss of $33.5M in fiscal year 2025. This represents an increase of 52.1% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $153.1M in net income. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Arbutus Biopharma Corporation has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ABUS Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | TTM | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $153.1M | -$33.5M+52.1% | -$69.9M+4.0% | -$72.8M-4.9% | -$69.5M+8.9% | -$76.2M-19.6% | -$63.7M+58.5% | -$153.7M-169.4% | -$57.1M+32.4% | -$84.4M+78.0% | -$384.2M-512.5% | -$62.7M-61.5% | -$38.8M-176.2% | -$14.1M-147.5% | $29.6M+393.7% | -$10.1M |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
ABUS Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Arbutus Biopharma Corporation financials
Frequently Asked Questions
What was Arbutus Biopharma Corporation's net income in fiscal year 2025?
Arbutus Biopharma Corporation reported a net loss of $33.5M in fiscal year 2025.
How fast is Arbutus Biopharma Corporation's net income growing?
Arbutus Biopharma Corporation (ABUS) net income rose by 52.1% year over year, from -$69.9M to -$33.5M in fiscal year 2025.
What is Arbutus Biopharma Corporation's net income over the last twelve months?
Arbutus Biopharma Corporation (ABUS) reported $153.1M in net income over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Arbutus Biopharma Corporation's net income changed over the years?
Across the 15 fiscal years this page covers, Arbutus Biopharma Corporation (ABUS) net income went from -$10.1M in fiscal year 2011 to -$33.5M in fiscal year 2025.
What was Arbutus Biopharma Corporation's net income in the most recent quarter?
Arbutus Biopharma Corporation (ABUS) reported -$5.1M in net income in Q2 2026. This represents a decrease of 303.8% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Arbutus Biopharma Corporation (ABUS) reported on that line in every period on record.